At the start of an unprecedented meeting of vaccine committee of the US Centers for Disease Control and Prevention, the ...

Denali Therapeutics' experimental drug for amyotrophic lateral sclerosis (ALS) failed to show efficacy in part of the phase 2/3 HEALEY ALS basket trial, causing a fall in its share price.

Shares in Neurocrine Bioscience took a tumble after the company reported mid-stage data for a key pipeline drug for schizophrenia that failed to impress investors. The 19% after-market selloff ...

The firm's Clinical Viewer is cleared for use with the Hamamatsu NanoZoomer S360MD Slide scanner, NDPI image formats, and the Barco NV MDPC-8127 display.

Get the latest news and real-time alerts from The Goldman Sachs Group, Inc. (GS) stock at Seeking Alpha.